Category: Federal


CDC Warns of Increasing Seasonal Influenza Activity

Today, the U.S. Centers for Disease Control and Prevention (CDC) issued a national health advisory about increased influenza A(H3N2) activity that could mark the beginning of the 2021-22 influenza season. The CDC notes that while influenza activity is still low overall nationally, an increase of the influenza strain A(H3N2) has been detected in recent weeks…

Read More »

HHS Announces $35m Investment in Title X Telehealth Services

The U.S. Department of Health and Human Services (HHS) this week announced the availability of $35 million in American Rescue Plan Act (ARPA) funding to enhance and expand the telehealth infrastructure and capacity of Title X family planning providers. According to HHS, telehealth adoption in the U.S. has increased dramatically and Title X grantees have…

Read More »

HHS Publishes Report on Surprise Medical Bills

The U.S. Department of Health and Human Services (HHS) this week released a new report finding that millions of Americans with private health insurance experience some kind of surprise medical billing. The report, developed by the HHS Office of Assistant Secretary for Planning and Evaluation, found that surprise medical bills are relatively common and can…

Read More »

NACCHO LHD Practice Awards Applications Due December 31

The National Association of County and City Health Officials (NACCHO) recently announced it has begun accepting applications for its 2022 Model and Innovative Practice Awards. Every year, NACCHO’s Model Practices Program nationally honors and recognizes outstanding local public health practice and shares them through the Model Practices Database. Model Practices are awarded to local health…

Read More »

CDC Reports Record High Overdose Deaths

The U.S. Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS) this week released provisional figures finding that drug overdose deaths passed for the first time 100,000 during a 12-month period from April 2020-April 2021, representing an increase of nearly 30 percent from the previous year. In California, a nearly 48…

Read More »

Eligibility for COVID-19 Boosters Expanded to All Adults

Today, the U.S. Food and Drug Administration (FDA) amended the emergency use authorizations (EUAs) for the Moderna and Pfizer-BioNTech COVID-19 vaccines, authorizing the use of a single booster dose for all individuals 18 years of age and older after completion of the primary vaccination with any FDA-authorized or approved COVID-19 vaccine. Prior to today’s announcement,…

Read More »

Biden-Harris Administration to Procure 10m Courses of COVID-19 Oral Antiviral

This week, the Biden-Harris Administration announced it has secured 10 million treatment courses for Pfizer’s COVID-19 oral antiviral drug, pending an emergency use authorization (EUA) or approval from the U.S. Food and Drug Administration (FDA). The investigational drug, Paxlovid, is under development to treat non-hospitalized, symptomatic adults diagnosed with COVID-19 who are at an increased…

Read More »

Appeals Court Stays Federal Vaccine Mandate for Large Employers, Litigation Continues

Recall, last week, the Department of Labor (DOL) Occupational Safety and Health Administration (OSHA) issued an emergency temporary standard relative to COVID-19 protections and precautions for employers with 100 or more employees, including a requirement for employers to verify that employees are fully vaccinated or complete regular weekly testing. Shortly after the order was issued…

Read More »

Biden-Harris Administration Announces Additional Investments in COVID-19 Response

This week, the Biden-Harris Administration announced a series of new investments of American Rescue Plan Act (ARPA) funds to continue support of the country’s response to the COVID-19 pandemic. The funding announcement, according to the White House, is a direct response to the recommendations advanced by the COVID-19 Health Equity Task Force which delivered its…

Read More »

HHS to Invest $650m in COVID-19 Rapid Diagnostic Testing

The U.S. Department of Health and Human Services (HHS) this week announced it will invest $650 million from the American Rescue Plan Act (ARPA) to strengthen manufacturing capacity for quick, high-quality diagnostic testing through rapid point-of-care molecular tests. HHS notes as at-home testing increases, the need for follow-up testing in health care settings will also…

Read More »